STAT3 and Granuloma: Importantly, MIA-602, also reduced inflammation and fibrosis in a mouse model of lung injury, by inhibiting inflammatory pathways, such as signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa-B (NF-kB) [26,27], and decreased inflammation in sarcoidosis-like granuloma [28].